Classical hallucinogens as antidepressant drugs [Editorial]: a cautionary approach (2023)
- Authors:
- USP affiliated authors: SANTOS, RAFAEL GUIMARÃES DOS - FMRP ; HALLAK, JAIME EDUARDO CECILIO - FMRP ; ROSSI, GIORDANO NOVAK - FMRP
- Unidade: FMRP
- DOI: 10.2174/1570159X20666220425133824
- Subjects: ALUCINOGÊNICOS; ANTIDEPRESSIVOS; DEPRESSÃO; ANSIEDADE; ENSAIO CLÍNICO CONTROLADO RANDOMIZADO; EDITORIAL
- Agências de fomento:
- Language: Inglês
- Imprenta:
- Source:
- Título do periódico: Current Neuropharmacology
- ISSN: 1570-159X
- Volume/Número/Paginação/Ano: v. 21, n. 1, p. 10-12, 2023
- Este periódico é de assinatura
- Este artigo é de acesso aberto
- URL de acesso aberto
- Cor do Acesso Aberto: green
-
ABNT
SANTOS, Rafael Guimarães dos et al. Classical hallucinogens as antidepressant drugs [Editorial]: a cautionary approach. Current Neuropharmacology. Sharjah: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. Disponível em: https://doi.org/10.2174/1570159X20666220425133824. Acesso em: 23 maio 2024. , 2023 -
APA
Santos, R. G. dos, Rossi, G. N., Hallak, J. E. C., Öngür, D., & Dursun, S. M. (2023). Classical hallucinogens as antidepressant drugs [Editorial]: a cautionary approach. Current Neuropharmacology. Sharjah: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. doi:10.2174/1570159X20666220425133824 -
NLM
Santos RG dos, Rossi GN, Hallak JEC, Öngür D, Dursun SM. Classical hallucinogens as antidepressant drugs [Editorial]: a cautionary approach [Internet]. Current Neuropharmacology. 2023 ; 21( 1): 10-12.[citado 2024 maio 23 ] Available from: https://doi.org/10.2174/1570159X20666220425133824 -
Vancouver
Santos RG dos, Rossi GN, Hallak JEC, Öngür D, Dursun SM. Classical hallucinogens as antidepressant drugs [Editorial]: a cautionary approach [Internet]. Current Neuropharmacology. 2023 ; 21( 1): 10-12.[citado 2024 maio 23 ] Available from: https://doi.org/10.2174/1570159X20666220425133824 - Safety issues of psilocybin and LSD as potential rapid acting antidepressants and potential challenges
- The effects of ketamine and classic hallucinogens on neurotrophic and inflammatory markers in unipolar treatment-resistant depression: a systematic review of clinical trials
- Tripping to cope: coping strategies and use of hallucinogens during the COVID-19 pandemic in three cultural contexts
- Molecular pathways of the therapeutic effects of Ayahuasca, a botanical psychedelic and potential rapid-acting antidepressant
- Natural hallucinogens in mental health [Editorial]
- Effects of ayahuasca on mental health and quality of life in naïve users: a longitudinal and cross-sectional study combination
- Therapeutic use of serotoninergic hallucinogens: a review of the evidence and of the biological and psychological mechanisms
- Adverse effects after Ayahuasca administration in the clinical setting [Carta]
- Polypharmacology or “pharmacological promiscuity” in psychedelic research: what are we missing?
- Ayahuasca and public health: health status, psychosocial well-being, lifestyle, and coping strategies in a large sample of ritual Ayahuasca users
Informações sobre o DOI: 10.2174/1570159X20666220425133824 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas